(Q34679433)

3 August 2017

Three-year variability in plasma concentrations of the soluble receptor for advanced glycation end products (sRAGE) (English)

1 reference

3 August 2017

2

1 reference

3 August 2017

Marc K Halushka

7

0 references

Ron C Hoogeveen

object named as

Ron C Hoogeveen

5

0 references

Mariana Lazo

3

object named as

Mariana Lazo

1 reference

3 August 2017

9

Elizabeth Selvin

1 reference

3 August 2017

Christie M. Ballantyne

6

object named as

Christie M Ballantyne

1 reference

3 August 2017

Julie K Bower

1

1 reference

3 August 2017

Eric Christenson

4

1 reference

3 August 2017

Brad C Astor

8

1 reference

3 August 2017

15 November 2013

1 reference

3 August 2017

Clinical Biochemistry

1 reference

3 August 2017

47

1 reference

3 August 2017

1-2

1 reference

3 August 2017

132-134

1 reference

sRAGE and risk of diabetes, cardiovascular disease, and death

3 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4263345

Dietary AGEs and ALEs and risk to human health by their interaction with the receptor for advanced glycation endproducts (RAGE)--an introduction

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4263345

Advanced glycation end products: sparking the development of diabetic vascular injury

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4263345

Advanced glycation end products and diabetic complications: a general overview.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4263345

Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4263345

Diabetes and advanced glycation endproducts

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4263345

Advanced glycation end-products: a review

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4263345

Tracking of glycated hemoglobin in the original cohort of the Framingham Heart Study.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4263345

The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4263345

Methodological and preanalytical evaluation of a RAGE immunoassay

7 July 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24246851

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.CLINBIOCHEM.2013.11.005

1 reference

3 August 2017

1 reference

3 August 2017

1 reference